Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Daihan Pharmaceutical Co Ltd

+ Add to Watchlist

023910:KS

21,050 KRW 250 1.20%

As of 01:18:09 ET on 03/06/2015.

Snapshot for Daihan Pharmaceutical Co Ltd (023910)

Open: 20,800 Day's Range: 20,500 - 21,150 Volume: 29,128
Previous Close: 20,800 52wk Range: 16,050 - 23,200 1-Yr Rtn: +8.75%

Stock Chart for 023910

No chart data available.
  • 023910:KS 21,050
  • 1D
  • 1M
  • 1Y
20,800
Interactive 023910 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 023910

Current P/E Ratio (ttm) 12.8589
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.4291
Earnings Per Share (ttm) 1,637.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 126,300.00
Shares Outstanding (M) 6.00
30 Day Average Volume 36,476
Price/Book (mrq) 1.9842
Price/Sale (ttm) 1.1905
Dividend Indicated Gross Yield 0.71%
Cash Dividend (KRW) 150.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 20.11%
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 023910

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 023910

Daihan Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products, such as parenterals, commonly known as intravenous (IV) fluids. The Company also produces other pharmaceutical products, including injectables, antibiotics, nutritional supplements, and anesthetics. Daihan supplies its products to hospitals and private pharmacies through its own sales network.

Kim Dong-SinVice ChairmanLee Yoon-WooRep Director
An Yeong-DonSenior Managing DirectorKim Myeong-HwanManaging Director
More Company Profile & Key Executives for 023910

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil